Author(s):
Geetanjali Sahu, Mohd Kaish Noori
Email(s):
geetanjali.sahu574@gmail.com , mdkaishnoori@gmail.com
DOI:
10.52711/2231-5713.2026.00035 
Address:
Geetanjali Sahu1, Mohd Kaish Noori2
1Assistant Professor (Pharmaceutics), School of Pharmacy, Chouksey Engineering College, Lalkhadan, Bilaspur, Chhattisgarh, Pincode 495004, India.
2Assistant Professor (Pharmaceutics), School of Pharmacy, Chouksey Engineering College, Lalkhadan, Bilaspur, Chhattisgarh, Pincode 495004, India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 3,
Year - 2026
ABSTRACT:
Morus alba (white mulberry) is an extensively studied medicinal plant recognised for its diverse therapeutic roles, especially in metabolic disorders such as type 2 diabetes mellitus (T2DM). Phytoconstituents including iminosugars (1-deoxynojirimycin, DNJ), flavonoids (rutin, quercetin derivatives), phenolic acids, and polysaccharides demonstrate promising antihyperglycaemic, antioxidant, anti-inflammatory, and lipid-modulating properties. Preclinical investigations validate its ability to inhibit carbohydrate-digesting enzymes, enhance insulin signalling, modulate gut microbiota, protect pancreatic ß-cells, and regulate oxidative stress. Emerging clinical evidence further supports its modulation of postprandial glucose and lipid markers. Despite encouraging findings, human trials remain limited by short duration, small sample sizes, and lack of extract standardisation. This review synthesizes updated phytochemistry, mechanistic insights, experimental evidence, clinical relevance, safety considerations, and future research directions, highlighting Morus alba as a potential adjunct in metabolic disease management rather than a standalone therapy.
Cite this article:
Geetanjali Sahu, Mohd Kaish Noori. Review on white Mulberry for the management of Diabetes. Asian Journal of Pharmacy and Technology. 2026; 16(3):246-8. doi: 10.52711/2231-5713.2026.00035
Cite(Electronic):
Geetanjali Sahu, Mohd Kaish Noori. Review on white Mulberry for the management of Diabetes. Asian Journal of Pharmacy and Technology. 2026; 16(3):246-8. doi: 10.52711/2231-5713.2026.00035 Available on: https://ajptonline.com/AbstractView.aspx?PID=2026-16-3-5
11. REFERENCES:
1. Jeong HI, Jang S, Kim KH. Morus alba L. for Blood Sugar Management: A Systematic Review and Meta Analysis. Evid Based Complement Alternat Med. 2022; 2022: 9282154. PMID: 35656460.
2. Sangiovanni E, et al. Medicinal properties of Morus alba for the control of type 2 diabetes mellitus: a systematic review. Rev Bras Farmacogn. 2022; 32(5): PMID: 34912543.
3. Upala S, et al. A meta analysis of efficacy of Morus alba Linn. to improve blood glucose and lipid profile. J Ethnopharmacol. 2016; 191: 95 102. PMID: 26972284.
4. Sung Y‐T, et al. The Effects of Supplementary Mulberry Leaf (Morus alba) Extracts on the Trace Element Status (Fe, Zn and Cu) in Relation to Diabetes Management and Antioxidant Indices in Diabetic Rats. Biol Trace Elem Res. 2016; 172(1): 129 38. doi:10.1007/s12011 016 0696 1.
5. Lee T, et al. Mulberry (Morus alba L.) Leaf Extract and 1 Deoxynojirimycin Improve Skeletal Muscle Insulin Resistance via the Activation of IRS 1/PI3K/Akt Pathway in db/db Mice. J Diabetes Res. 2022; 2022: PMID: 36295064.
6. Zhang W, et al. Administration of mulberry leaves maintains pancreatic β cell mass in obese/type 2 diabetes mellitus mouse model. BMC Complement Med Ther. 2020; 20: 136. doi:10.1186/s12906 020 02933 4.
7. Asai A, et al. Suppressive Effect of Extractive from Leaves of Morus alba with α Glucosidase Inhibitors on Human Postprandial Blood Glucose Elevation Induced by Starchy Foods. Eiyogaku Zasshi. 2010; 68(6): 351 8. PMID: …
8. Ling W, et al. Evaluation of a Standardized Extract from Morus alba against α Glucosidase Inhibitory Effect and Postprandial Antihyperglycemic in Patients with Impaired Glucose Tolerance: A Randomised Double Blind Clinical Trial. Phytomedicine. 2017; 34: 39 45. PMID: 27974904.
9. Azimi Y, et al. Morus alba leaf extract affects metabolic profiles, biomarkers inflammation and oxidative stress in patients with type 2 diabetes mellitus: a double‐blind clinical trial. Clin Nutr. 2022; 41(2): PMID: 35623877.
10. Yanagida O, et al. Bioequivalence of Mulberry Fruit Extract and 1 Deoxynojirimycin for Postprandial Blood Glucose Lowering: A Randomised Trial in Humans. Nutrients. 2023; 15(4): PMID:40419090.
11. Jiao Y, et al. Antidiabetic effects of Morus alba fruit polysaccharides on high‐fat diet‐ and streptozotocin‐induced type 2 diabetes in rats. J Ethnopharmacol. 2017; 208: 48 57. doi: 10.1016/j.jep.2017.02.003. NutraIngredients.com
12. Alrawi NNR. The Effect of White Mulberry (Morus alba) Leaf Extract on Blood Glucose Reduction: An Experimental Study on Animal Models with a Focus on Mechanistic Insights. Am J Biol Nat Sci. 2025; 2(2): 562.
13. Zhou Y, et al. A Systematic review on the phytochemistry, isolated compounds, nutritional benefits, pharmacology and toxicology of the plant species Morus alba L. Discover Plants. 2025; 2: 7. doi:10.1007/s44372 024 00043 w.
14. Nishimoto Y, Ikeda Y, Qiao Y, Minami H, Ito M, Kimura T, Yasukawa K. The relationship between 1 deoxynojirimycin content and alpha glucosidase inhibitory activity in leaves of 276 mulberry cultivars (Morus spp.) in Kyoto, Japan. J Agric Food Chem. 2008; 56(12): 4174 9. PMID: 18404344.
15. Reddy M, Shaik AH. Comparative study of hypoglycemic activity of Morus alba with oral glibenclamide in streptozotocin induced diabetic rats. Int J Basic Clin Pharmacol. 2019; 8(5): 1091 5. doi:10.18203/2319 2003.ijbcp20190663.